Filing Details
- Accession Number:
- 0001209191-11-027025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-09 16:18:25
- Reporting Period:
- 2011-05-09
- Filing Date:
- 2011-05-09
- Filing Date Changed:
- 2011-05-09
- Accepted Time:
- 2011-05-09 17:18:25
- Original Submission Date:
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 786947 | Acura Pharmaceuticals, Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1058352 | G William Skelly | C/o Acura Pharmaceuticals, Inc. 616 N. North Court Palatine IL 60067 |
Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings |
|---|---|---|---|---|---|
| Common Stiock | Disposition | 2011-05-09 | 5,000 | $4.27 | 90,000 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Amount of securities include 75,000 remaining Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.
Insider Monkey Small Cap Strategy
Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!
